Abstract
Treatment for hepatitis C virus is often complicated by anaemia from ribavirin-related haemolysis and bone marrow suppression because of peginterferon alfa. An extensive literature search revealed no reports of drug interactions between ribavirin and oseltamivir. We report the case of a patient with chronic hepatitis C infection who developed severe anaemia during antiviral treatment with peginterferon alfa/ribavirin when oseltamivir was added to treat influenza. The adverse events related to ribavirin and drug-drug interactions during therapy for hepatitis C are discussed. © 2012 Blackwell Publishing Ltd.
| Original language | English |
|---|---|
| Pages (from-to) | 14-17 |
| Journal | Journal of Viral Hepatitis |
| Volume | 19 |
| Issue number | SUPPL. 1 |
| DOIs | |
| Publication status | Published - 1 Jan 2012 |
Keywords
- anaemia
- chronic hepatitis C
- drug interaction
- influenza A
